These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 16970054)

  • 1. Increased plasma homocysteine and allantoin levels in coronary artery disease: possible link between homocysteine and uric acid oxidation.
    Ozkan Y; Yardim-Akaydin S; Imren E; Torun M; Simşek B
    Acta Cardiol; 2006 Aug; 61(4):432-9. PubMed ID: 16970054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine plasma level correlates with homocysteine and uric acid concentrations in patients with coronary artery disease.
    Fromonot J; Deharo P; Bruzzese L; Cuisset T; Quilici J; Bonatti S; Fenouillet E; Mottola G; Ruf J; Guieu R
    Can J Physiol Pharmacol; 2016 Mar; 94(3):272-7. PubMed ID: 26762617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum allantoin and aminothiols as biomarkers of chronic heart failure.
    Caussé E; Fournier P; Roncalli J; Salvayre R; Galinier M
    Acta Cardiol; 2017 Aug; 72(4):397-403. PubMed ID: 28705092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of uric acid in rheumatoid arthritis: is allantoin a marker of oxidative stress?
    Yardim-Akaydin S; Sepici A; Ozkan Y; Torun M; Simşek B; Sepici V
    Free Radic Res; 2004 Jun; 38(6):623-8. PubMed ID: 15346653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
    Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
    Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of folic acid and N-acetylcysteine on plasma homocysteine levels and endothelial function in patients with coronary artery disease.
    Yilmaz H; Sahin S; Sayar N; Tangurek B; Yilmaz M; Nurkalem Z; Onturk E; Cakmak N; Bolca O
    Acta Cardiol; 2007 Dec; 62(6):579-85. PubMed ID: 18214123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urate oxidation during percutaneous transluminal coronary angioplasty and thrombolysis in patients with coronary artery disease.
    Yardim-Akaydin S; Kesimer M; Imren E; Sepici A; Simşek B; Torun M
    Clin Chim Acta; 2005 Dec; 362(1-2):131-7. PubMed ID: 15992789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid and allantoin levels in Down syndrome: antioxidant and oxidative stress mechanisms?
    Zitnanová I; Korytár P; Aruoma OI; Sustrová M; Garaiová I; Muchová J; Kalnovicová T; Pueschel S; Duracková Z
    Clin Chim Acta; 2004 Mar; 341(1-2):139-46. PubMed ID: 14967170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monitoring of allantoin, uric acid, and malondialdehyde levels in plasma and erythrocytes after ten minutes of running activity.
    Kanďár R; Štramová X; Drábková P; Křenková J
    Physiol Res; 2014; 63(6):753-62. PubMed ID: 25157658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allantoin as a marker of oxidative stress in human erythrocytes.
    Kand'ár R; Záková P
    Clin Chem Lab Med; 2008; 46(9):1270-4. PubMed ID: 18636793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma homocysteine levels in patients with isolated coronary artery ectasia.
    Turhan H; Erbay AR; Yasar AS; Bicer A; Sahin O; Basar N; Yetkin E
    Int J Cardiol; 2005 Sep; 104(2):158-62. PubMed ID: 16168808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum uric acid level and the severity of coronary artery disease in patients with obstructive coronary artery disease.
    Yu J; Han J; Mao J; Guo L; Gao W
    Chin Med J (Engl); 2014; 127(6):1039-45. PubMed ID: 24622431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between uric acid and its oxidative product allantoin: a potential indicator for the evaluation of oxidative stress in birds.
    Tsahar E; Arad Z; Izhaki I; Guglielmo CG
    J Comp Physiol B; 2006 Sep; 176(7):653-61. PubMed ID: 16705445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminothiols and allantoin in chronic dialysis patients: effects of hemodialysis sessions.
    Caussé E; Ribes D; Longlune N; Kamar N; Durand D; Salvayre R; Rostaing L
    Clin Nephrol; 2010 Jan; 73(1):51-7. PubMed ID: 20040352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperhomocysteinemia measured by immunoassay: a valid measure of coronary artery atherosclerosis.
    Stauffenberg MT; Lange RA; Hillis LD; Cigarroa J; Hsu RM; Devaraj S; Jialal I
    Arch Pathol Lab Med; 2004 Nov; 128(11):1263-6. PubMed ID: 15504061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Related factors of serum uric acid in patients with primary hypertension and hyperhomocysteinemia.
    Wang B; Lin L; Zhao C
    Clin Exp Hypertens; 2016; 38(3):312-6. PubMed ID: 27028508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of methionine synthase (A2756G) and methionine synthase reductase (A66G) polymorphisms on plasma homocysteine levels and relation to risk of coronary artery disease.
    Laraqui A; Allami A; Carrié A; Coiffard AS; Benkouka F; Benjouad A; Bendriss A; Kadiri N; Bennouar N; Benomar A; Guedira A; Raisonnier A; Fellati S; Srairi JE; Benomar M
    Acta Cardiol; 2006 Feb; 61(1):51-61. PubMed ID: 16485733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation products of uric acid and ascorbic acid in preterm infants with chronic lung disease.
    Ogihara T; Kim HS; Hirano K; Imanishi M; Ogihara H; Tamai H; Okamoto R; Mino M
    Biol Neonate; 1998; 73(1):24-33. PubMed ID: 9458939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
    Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
    Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma total homocysteine levels in patients with early-onset coronary heart disease and a low cardiovascular risk profile.
    Donner MG; Klein GK; Mathes PB; Schwandt P; Richter WO
    Metabolism; 1998 Mar; 47(3):273-9. PubMed ID: 9500562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.